Evidence map›Paper›PMID 20064241›Full record

ArticleJournal of neuroinflammation2010

Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia.

Johannes C M Schlachetzki, Bernd L Fiebich, Elisabeth Haake, Antonio C P de Oliveira, Eduardo Candelario-Jalil, Michael T Heneka, Michael Hüll

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Mechanisms of comorbidity between Alzheimer's disease and pain.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  5. Neuroprotective actions of norepinephrine in neurological diseases.Pflugers Archiv : European journal of physiology · 2024
    Review
  6. Article
  7. Receptors on Microglia.Advances in neurobiology · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target.International journal of molecular sciences · 2022
    Review
  15. Suppressive Effect of Tetrahydrocurcumin onOxidative medicine and cellular longevity · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. The link between chronic pain and Alzheimer's disease.Journal of neuroinflammation · 2019
    Review
  20. Renal sympathetic nerve activation via αKidney research and clinical practice · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Johannes C M SchlachetzkiDepartment of Psychiatry and Psychotherapy, University Hospital of Freiburg, Freiburg, Germany.
Bernd L Fiebich
Elisabeth Haake
Antonio C P de Oliveira
Eduardo Candelario-Jalil
Michael T Heneka
Michael Hüll
University Medical Center Freiburg · DEUniversity of Bonn · DEUniversity of New Mexico · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies suggest an important role for neurotransmitters as modulators of inflammation. Neuroinflammatory mediators such as cytokines and molecules of the arachidonic acid pathway are generated and released by microglia. The monoamine norepinephrine reduces the production of cytokines by activated microglia in vitro. However, little is known about the effects of norepinephrine on prostanoid synthesis. In the present study, we investigate the role of norepinephrine on cyclooxygenase- (COX-)2 expression/synthesis and prostaglandin (PG)E2 production in rat primary microglia.

resultsInterestingly, norepinephrine increased COX-2 mRNA, but not protein expression. Norepinephrine strongly enhanced COX-2 expression and PGE2 production induced by lipopolysaccharide (LPS). This effect is likely to be mediated by beta-adrenoreceptors, since beta-, but not alpha-adrenoreceptor agonists produced similar results. Furthermore, beta-adrenoreceptor antagonists blocked the enhancement of COX-2 levels induced by norepinephrine and beta-adrenoreceptor agonists.

conclusionsConsidering that PGE2 displays different roles in neuroinflammatory and neurodegenerative disorders, norepinephrine may play an important function in the modulation of these processes in pathophysiological conditions.

Indexed as

Adrenergic alpha-AgonistsAdrenergic beta-AntagonistsAnalysis of VarianceAnimalsAnimals, NewbornCells, CulturedCerebral CortexCyclooxygenase 2DinoprostoneDose-Response Relationship, DrugGene Expression Regulation, EnzymologicImidazolesImmunoenzyme TechniquesLipopolysaccharidesMicrogliaNorepinephrineAdrenergic alpha-AgonistsAdrenergic beta-AntagonistsCGP 20712ACyclooxygenase 2DinoprostoneICI 118551ImidazolesLipopolysaccharidesNorepinephrinePropanolaminesRNA, Messenger

Identifiers

PMID20064241
PMCPMC2819253
OpenAlexW2149789821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.